Furthermore, patients exhibiting low infiltration of Texterm and Texprog cells in the stroma, low Texprog in the TME, or low PD‐1+CD8+ T cells in the stromalp or tumor area tended to have better progression‐free survival (PFS) (Figure S1, Supporting Information). This evidence concerns the gene CD8A and neoplasm.